Showing results (1-10 of 520) with videos related to
Sort By:
Pageof 52
Cancer Cell|April 11, 2018
Emerging Concepts for Immune Checkpoint Blockade-Based Combination TherapiesRoberta Zappasodi, Taha Merghoub, Jedd D WolchokCurrent Hematologic Malignancy Reports|August 31, 2018
Strategies for Predicting Response to Checkpoint InhibitorsRoberta Zappasodi, Jedd D Wolchok, Taha MerghoubCurrent Hematologic Malignancy Reports|November 9, 2018
Correction to: Strategies for Predicting Response to Checkpoint InhibitorsRoberta Zappasodi, Jedd D Wolchok, Taha MerghoubImmunotherapy|August 28, 2015
Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinationsRoberta Zappasodi, Taha MerghoubOncoimmunology|March 26, 2013
Myeloid-derived suppressor sells and the efficacy of CD8<sup>+</sup> T-cell immunotherapyAlexander M Lesokhin, Taha Merghoub, Jedd D WolchokCancer Cell|April 5, 2024
Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effectsLukas Kraehenbuehl, Jedd D Wolchok, Taha Merghoub, et al.Nature Reviews. Clinical Oncology|September 28, 2021
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathwaysLukas Kraehenbuehl, Chien-Huan Weng, Shabnam Eghbali, et al.Ebiomedicine|May 24, 2016
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumorsRikke B Holmgaard, Dmitriy Zamarin, Alexander Lesokhin, et al.Science Advances|February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanismChanghao He, Rachana R Maniyar, Yahel Avraham, et al.Pageof 52